Recently, the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Development and Growth of the Private Economy" was published. The document stated that "the private economy is a new force to promote Chinese-style modernization" and issued 31 practical measures. The latest special report of CCTV News "Step by Step | Look at the 2023 Half-Year Economy" column takes stock of the development of the private economy in 2023, and pays attention to RoboCT's rehabilitation exoskeleton.

RoboCT continues to develop and innovate, and has introduced the first domestic automated assembly line for the production of exoskeleton robots. The production and manufacturing capabilities of exoskeleton robots have been greatly improved, the production process is more accurate and efficient, the error rate and difficulty of manual intervention are reduced, and production efficiency is improved.

At the same time, RoboCT believes that enterprise R&D is one of the important means to obtain core competitiveness, and 50% of the annual R&D investment is conducive to improving the technical level and innovation ability, enhancing its own brand image, and establishing industry reputation and status. Continuous investment in R&D is one of the necessary conditions for an enterprise to build its core competitiveness. Only through continuous R&D, innovation and technological progress can an enterprise occupy a strong position in the market and achieve long-term stable development.

In the first half of this year, RoboCT's rehabilitation exoskeleton orders increased by 300%. This is the result of the company's continuous efforts and research and development results over the years, and it also proves the potential and urgent demand for exoskeleton equipment in the market. With the aging problem and the continuous improvement of human robotics technology, exoskeleton devices have become a hot topic that has attracted much attention. RoboCT's exoskeleton equipment export zero breakthrough is a major breakthrough in the international market for Chinese-made exoskeleton equipment.